Hair loss is a highly noticeable ageing sign. For most it can be an extremely distressful period moreover if experienced from a young age. Some people accept it whilst others seek treatment to slow down, stop or even overturn the process. Numerous hair loss treatment adverts prove just how big this business is. The advantage to the big business approach is that research on hair loss and treatment is always continuous and active and has lead to the launch of Dercos on the market by the L’oreal laboratories in France.

How does Dercos work?

This is the first patented product presented to the market that is specially designed so that it can battle and stop perifollicular fibrosis. Dercos consists of Aminexil which is a fairly new drug developed by Vichy, a company based in France.

Dercos is able to raise hair volume in its growth stage by functioning on the deep structure of the roots. It achieves this by softening collagen and aiding the hair root to stay in the scalp instead of being driven upwards. The hair volume in the growth period is also raised.

Whats more Dercos has clinically proven to considerably hold onto current hair growth, and enhance the condition along with hair thickness. A key example involving a yearlong study with 350 women and men in which they were signed up to identify the effects of using Dercos regularly. After a 6 week clinical trial there was 8% improvement in hair thickness, condition and quantity with those using dercos in comparison to placebo users. After 8 weeks, dercos users revealed 6% more growth in hair then they had before. While those on the placebo lost 3% of their growing hair.

Other results involving Dercos use include:
• A stronger effect discovered by 70 % of users
• 69 participant tests showed how 80% found dercos had improved the volume and strength
• The texture and scent of dercos is enjoyed and recognised by over 90% of user.